Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives. The company also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. It exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
Low
819.00
High
1,418.00
Low
1,331.10
High
1,384.70
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Alivus Life Sciences Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ALIVUS Alivus Life Sciences Limited | 1,357.00 | 0.95% | 27.68 | 49.03 | 16,506 | 17.17% | 28.10% | 1,418.00 / 819.00 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 418.00 | 0.78% | 19.97 | 20.93 | 3,815 | 5.53% | 20.38% | 534.55 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 816.10 | 1.59% | 34.73 | 23.50 | 7,400 | 13.69% | 14.28% | 946.10 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,250.00 | 0.50% | 34.55 | 759.88 | 55,774 | 4.25% | 23.36% | 32,900.00 / 25,150.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 14.38 | 0.07% | 5.93 | 2.42 | 764 | 5.95% | 58.02% | 17.27 / 9.08 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,650.00 | 0.24% | 40.18 | 90.83 | 45,595 | 6.17% | 30.87% | 3,796.00 / 2,329.90 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 750.00 | 0.39% | 39.37 | 19.05 | 11,483 | 9.97% | 35.62% | 775.00 / 409.30 |
| 8 | ALKEM Alkem Laboratories Limited | 5,395.00 | 0.09% | 29.90 | 180.45 | 64,536 | 2.73% | 7.93% | 5,933.50 / 5,075.00 |
| 9 | AMRUTANJAN Amrutanjan Health Care Limited | 533.25 | 2.22% | 28.56 | 18.67 | 1,541 | 0.38% | 23.27% | 790.95 / 482.80 |
| 10 | APLLTD Alembic Pharmaceuticals Limited | 818.75 | 0.57% | 23.22 | 35.27 | 16,150 | 0.15% | 20.51% | 998.00 / 635.80 |
| 11 | ASTRAZEN AstraZeneca Pharma India Limited | 7,400.00 | 1.43% | 109.07 | 67.85 | 18,500 | 11.24% | 18.49% | 9,849.50 / 7,371.50 |
| 12 | AUROPHARMA Aurobindo Pharma Limited | 1,614.90 | 0.43% | 25.23 | 64.00 | 92,918 | 4.09% | 41.78% | 1,682.40 / 1,016.10 |
| 13 | BAJAJHCARE Bajaj HealthCare Limited | 321.10 | 1.49% | 61.28 | 5.24 | 1,081 | 6.43% | 39.35% | 515.90 / 272.35 |